Publication

Article

Supplements and Featured Publications

Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Volume

Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%

This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo